| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Adler Eric is a Chief Medical Officer at LXEO. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $355K at current prices.
Our model assigns Adler Eric a below-average insider score of 32/100, based on 5 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -48.8%.
Adler Eric's largest disclosed position is in LXEO as Chief Medical Officer, worth about $355K. The recent filings there lean toward selling, a net 7,549 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 615 | $9.27 | $5,701.05 | -0.8% | -31.6% | - | |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 3,382 | $8.94 | $30,241.96 | -2.3% | -21.7% | - | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 608 | $4.67 | $2,838.14 | -0.9% | +92.7% | - | |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 585 | $2.77 | $1,622.79 | -0.9% | +47.8% | +57.1% | |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 2,359 | $4.41 | $10,410.27 | -3.3% | -20.9% | +40.6% |